Skip to main content

​
Overview

CL-17 connects Encore to the Arizona CSPMP through a vendor-agnostic adapter (CL-17-EN-01): the production vendor is a configuration choice, not a code change. Until a gateway vendor is contracted, the electronic path stays off and prescribers use the built-in manual portal flow — which fully satisfies the prescriber duty under A.R.S. § 36-2606(F). Two distinct obligations matter:

​
Configuration (cl_pdmp_configuration, one row per organization)

  1. File the Integration Interest Form via Bamboo Customer Connect (connect.bamboohealth.com, linked from pharmacypmp.az.gov/pmp-integration). Arizona state-funds Gateway for non-federal healthcare entities — no license charge. New-vendor onboarding takes weeks to months: start early.
  2. Sign the state Terms & Conditions; the AZ Board of Pharmacy approves the organization (~1 week) and Bamboo schedules the technical engagement.
  3. Platform team implements the Bamboo XML call behind the existing adapter and stores credentials in the vault (credentials_vault_ref).
  4. Set pdmp_adapter_enabled = true for the organization. Prescribers gain the Query PDMP button; the portal flow remains as fallback.
Note: Arizona’s funded tier returns the basic PMP report — NarxCare risk scores are not included — so risk indicators may be absent from results.

​
Permissions (PF-30)

​
Compliance notes

  • Every check writes an immutable cl_pdmp_queries audit row (PHI table, org-scoped RLS). Manual portal checks record “checked + reviewed” in one action; gateway outages are recorded automatically (exception_type) as safe-harbor evidence.
  • AHCCCS (AMPM 940) requires the medical record to show CSPMP use before prescribing controlled substances — the chart’s PDMP history is that evidence.
  • Do not attempt to embed or scrape the AWARxE portal: embedding is blocked by the state (X-Frame-Options), and automated portal access is legally restricted (A.R.S. § 36-2604(C), § 36-2610(D)).
  • Full connectivity research and citations: specs/cl/research/CL-17-EN-01-RESEARCH.md.